Supplementary Table 1.

Articles Included in the Delay-Stage Meta-analysis

Article	Year	Country	Age (y)	Delay (mo)	Stage	n CRC	n total CRC
Beshara et al	2019	Israel	50–74	0–3	1–2	377	753
Beshara et al	2019	Israel	50–74	0–3	3-	114
Beshara et al	2019	Israel	50–74	4–6	1–2	54
Beshara et al	2019	Israel	50–74	4–6	3–4	16
Beshara et al	2019	Israel	50–74	7–12	1–2	45
Beshara et al	2019	Israel	50–74	7–12	3–4	11
Beshara et al	2019	Israel	50–74	>12	1–2	106
Beshara et al	2019	Israel	50–74	>12	3–4	30
Corley et al	2017	USA	50–70	0–3	1–2	1017	1834
Corley et al	2017	USA	50–70	0–3	3–4	452
Corley et al	2017	USA	50–70	4–6	1–2	85
Corley et al	2017	USA	50–70	4–6	3–4	46
Corley et al	2017	USA	50–70	7–12	1–2	50
Corley et al	2017	USA	50–70	7–12	3–4	31
Corley et al	2017	USA	50–70	>12	1–2	81
Corley et al	2017	USA	50–70	>12	3–4	72
Flugelman et al	2019	Israel	50+	0–3	1–2	583	1419
Flugelman et al	2019	Israel	50+	0–3	3–4	230
Flugelman et al	2019	Israel	50+	4–6	1–2	193
Flugelman et al	2019	Israel	50+	4–6	3–4	60
Flugelman et al	2019	Israel	50+	7–12	1–2	93
Flugelman et al	2019	Israel	50+	7–12	3–4	30
Flugelman et al	2019	Israel	50+	>12	1–2	153
Flugelman et al	2019	Israel	50+	>12	3–4	77
Kaalby et al	2019	Denmark	50+	0–3	1–2	1498	3639
Kaalby et al	2019	Denmark	50+	0–3	3–4	716
Kaalby et al	2019	Denmark	50+	NA	1–2	1099
Kaalby et al	2019	Denmark	50+	NA	3–4	326
Kim et al	2019	Korea	50+	0–3	1–2	31	81
Kim et al	2019	Korea	50+	0–3	3–4	21
Kim et al	2019	Korea	50+	4–6	1–2	14
Kim et al	2019	Korea	50+	4–6	3–4	9
Kim et al	2019	Korea	50+	7–12	1–2	4
Kim et al	2019	Korea	50+	7–12	3–4	2
Lee et al	2019	Taiwan	50–69	0–3	1–2	1202	2003
Lee et al	2019	Taiwan	50–69	0–3	3–4	326
Lee et al	2019	Taiwan	50–69	4–6	1–2	255
Lee et al	2019	Taiwan	50–69	4–6	3–4	66
Lee et al	2019	Taiwan	50–69	7–12	1–2	81
Lee et al	2019	Taiwan	50–69	7–12	3–4	44
Lee et al	2019	Taiwan	50–69	>12	1–2	20
Lee et al	2019	Taiwan	50–69	>12	3–4	9
Rutter et ala	2018	USA	50–75	0–3	1–2	77	300
Rutter et ala	2018	USA	50–75	0–3	3–4	23
Rutter et ala	2018	USA	50–75	4–6	1–2	77
Rutter et ala	2018	USA	50–75	4–6	3–4	23
Rutter et ala	2018	USA	50–75	7–12	1–2	75
Rutter et ala	2018	USA	50–75	7–12	3–4	25
Zorzi et al	2020	Italy	50–69	0–3	1–2	2457	2981
Zorzi et al	2020	Italy	50–69	0–3	3–4	354
Zorzi et al	2020	Italy	50–69	4–6	1–2	111
Zorzi et al	2020	Italy	50–69	4–6	3–4	19
Zorzi et al	2020	Italy	50–69	7–12	1–2	28
Zorzi et al	2020	Italy	50–69	7–12	3–4	12

NOTE. n CRC represents the number of CRC cases for each delay and stage; n total CRC is the total number of CRC cases.

^aData from the MIcrosimulation SCcreening ANalysis-ColoRectal Cancer (MISCAN-colon) microsimulation model were used.